Pfizer, Flynn Pharma slapped with £70 million fine for massive price hike on epilepsy drug

The years-long saga of the Competition and Markets Authority (CMA)’s investigation into Pfizer and Flynn Pharma has come to a head with a combined 70 million pound ($83.61 million) fine. The U.K. antitrust authorities claim the companies exploited a loophole to massively hike prices.